New food solutions for cancer patients: a consumer-centred approach
SHARES
The Oncofood project revealed some expectations of cancer patients regarding new food solutions.
Cancer is among the leading causes of death worldwide. According to the Global Cancer Observatory, in 2018 there were 18.1 million new cases and 9.5 million cancer-related deaths worldwide.
1
One of the main challenges for cancer patients undergoing treatment is preventing or mitigating malnutrition. Cancer-related malnutrition is highly prevalent in patients undergoing cancer treatment, varying from eight to 84 percent, dependent on cancer site and stage.
2 However, not all patients suffer from malnutrition, but most experience a reduction in their daily food intake as they often have adverse side effects (eg, taste loss, bad taste in mouth, metallic taste, sores in mouth, vomiting, loss of appetite and dysphagia).
This press release was orginally distributed by SBWire
Edison, NJ (SBWIRE) 12/24/2020 A new business intelligence report released by HTF MI with title Global Clinical Nutrition Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread) is designed covering micro level of analysis by manufacturers and key business segments. The Global Clinical Nutrition Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are ABBOTT NUTRITION, Atrium Innovations, Glanbia Plc, Nestle SA, Baxter International, Lonza Group Ltd., Pfizer, Inc, Abbott Nutrition & DuPont Nutrition & Health.